Cargando…
Future Comorbidities in an Aging Cystic Fibrosis Population
Cystic fibrosis (CF) is an autosomal recessive disease due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. With the advent of highly effective modulator therapy targeting the abnormal CFTR protein, people with CF (PwCF) are living more than 40 years longer than t...
Autores principales: | Ticona, Javier Humberto, Lapinel, Nicole, Wang, Janice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301499/ https://www.ncbi.nlm.nih.gov/pubmed/37374088 http://dx.doi.org/10.3390/life13061305 |
Ejemplares similares
-
Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management
por: Patel, Dhiren, et al.
Publicado: (2022) -
Pregnancy in Cystic Fibrosis—Past, Present, and Future
por: Gur, Michal, et al.
Publicado: (2023) -
Evolving Nutritional Needs in Cystic Fibrosis
por: Frantzen, Theresa, et al.
Publicado: (2023) -
Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023) -
Cystic fibrosis: current therapeutic targets and future approaches
por: Rafeeq, Misbahuddin M., et al.
Publicado: (2017)